» Articles » PMID: 36276467

Cytotoxicity of Di-rhamnolipids Produced by RA5 Against Human Cancerous Cell Lines

Overview
Journal 3 Biotech
Publisher Springer
Specialty Biotechnology
Date 2022 Oct 24
PMID 36276467
Authors
Affiliations
Soon will be listed here.
Abstract

Rhamnolipid biosurfactant produced by , possesses non-toxicity, environmental compatibility, a wide range of pH (4-8), temperature (4-100 °C), and salinity (1-10%) stability. The application of RLs is worldwide accepted in the pharmaceutical, medicinal, and food industries. It has been used for cytotoxicity efficacy analysis with a limited number of cancerous cell lines. To widen the scope of rhamnolipid application as an anticancer agent, we have studied Di-RLs homolog, 'Rha-Rha-C10-C10' produced by RA5 against human cancerous cell lines including breast cancer (MCF-7), leukemia (K-562), cervical cancer (HeLa), Lung cancer (HOP-62), and colon cancer (HT-29) in a dose-dependent way. It was purified with silica gel chromatography followed by TLC and mass spectroscopy prior to cytotoxicity analysis. With a tensiometer, critical micelle concentration of Di-RLs was estimated to be 33.92 ± 2 mN/m at 0.2%. Cytotoxicity analysis of Di-RLs on K-562 cell line demonstrated inhibition with GI50 and TGI at < 10 µg/mL and 66.6 µg/mL, after 48 h of application. The morphology of human cancerous cell lines was observed under a laser confocal microscope with the SRB staining method. Further research is recommended to comprehend the Di-RLs as a potential anti-cancer agent.

Citing Articles

The Physicochemical and Functional Properties of Biosurfactants: A Review.

Dini S, Bekhit A, Roohinejad S, Vale J, Agyei D Molecules. 2024; 29(11).

PMID: 38893420 PMC: 11173842. DOI: 10.3390/molecules29112544.

References
1.
Isoda H, Nakahara T . Mannosylerythritol lipid induces granulocytic differentiation and inhibits the tyrosine phosphorylation of human myelogenous leukemia cell line K562. Cytotechnology. 2012; 25(1-3):191-5. PMC: 3466747. DOI: 10.1023/A:1007982909932. View

2.
Guo Y, Hu Y, Gu R, Lin H . Characterization and micellization of rhamnolipidic fractions and crude extracts produced by Pseudomonas aeruginosa mutant MIG-N146. J Colloid Interface Sci. 2008; 331(2):356-63. DOI: 10.1016/j.jcis.2008.11.039. View

3.
Rahman K, Rahman T, McClean S, Marchant R, Banat I . Rhamnolipid biosurfactant production by strains of Pseudomonas aeruginosa using low-cost raw materials. Biotechnol Prog. 2002; 18(6):1277-81. DOI: 10.1021/bp020071x. View

4.
. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

5.
Nayarisseri A, Singh P, Singh S . Screening, isolation and characterization of biosurfactant producing strain ANSKLAB03. Bioinformation. 2018; 14(6):304-314. PMC: 6137570. DOI: 10.6026/97320630014304. View